TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Moberg Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
|
207
|
0 |
Financial expenses |
260
|
72
|
240 |
Earnings before taxes |
-25,420
|
-19,512
|
-19,970 |
EBITDA |
-25,364
|
-17,644
|
-17,146 |
Total assets |
634,732
|
564,423
|
450,889 |
Current assets |
69,493
|
127,760
|
104,655 |
Current liabilities |
20,540
|
26,786
|
15,538 |
Equity capital |
610,725
|
533,584
|
434,051 |
- share capital |
27,961
|
9,827
|
4,405 |
Employees (average) |
10
|
8
![]() |
8 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
96.2%
|
94.5%
|
96.3% |
Turnover per employee |
0
|
26
|
0 |
Profit as a percentage of turnover | -9426.1% | ||
Return on assets (ROA) |
-4.0%
|
-3.4%
|
-4.4% |
Current ratio |
338.3%
|
477.0%
|
673.5% |
Return on equity (ROE) |
-4.2%
|
-3.7%
|
-4.6% |
Change turnover |
-207
|
207
|
-50,488 |
Change turnover % | -100% | -100% | |
Chg. No. of employees |
2
|
0
|
-3 |
Chg. No. of employees % |
25%
|
0%
|
-27% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.